Prognostic models for advanced melanoma patients treated with anti-PD-1 monotherapy.

被引：0
|
作者：
Bai, Xue
Kim, Michelle S.
Kasumova, Gyulnara G.
Cohen, Justine Vanessa
Lawrence, Donald P.
Freedman, Christine
Fadden, Riley
Rubin, Krista M.
Sharova, Tatyana
Flaherty, Keith
Sullivan, Ryan J.
Boland, Genevieve Marie
机构：
[1] MGH, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Ctr Canc, Surg Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 08期
关键词：
D O I：
10.1200/JCO.2019.37.8_suppl.133
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
133
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PD-L1 expression and outcome of advanced melanoma patients treated with anti-PD-1/PD-L1 agents: a meta-analysis
    Abdel-Rahman, Omar
    IMMUNOTHERAPY, 2016, 8 (09) : 1081 - 1090
  • [32] Prognostic Nomogram for Advanced Non-Small Cell Lung Cancer Patients Treated With Anti-PD-1 Inhibitors
    Chai, R.
    Fan, Y.
    Zhao, J.
    He, F.
    Han, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S254 - S255
  • [33] Anti-PD-1 Therapy in Melanoma
    Moreno, Blanca Hornet
    Parisi, Giulia
    Robert, Lidia
    Ribas, Anton
    SEMINARS IN ONCOLOGY, 2015, 42 (03) : 466 - 473
  • [34] Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma
    Aya, Francisco
    Gaba, Lydia
    Victoria, Ivan
    Fernandez-Martinez, Aranzazu
    Tosca, Monica
    Prat, Aleix
    Arance, Ana
    FUTURE ONCOLOGY, 2016, 12 (23) : 2683 - 2688
  • [35] Treatment Options for Advanced Melanoma After Anti-PD-1 Therapy
    Babacan, Nalan Akgul
    Eroglu, Zeynep
    CURRENT ONCOLOGY REPORTS, 2020, 22 (04)
  • [36] Role of Anti-PD-1 Antibodies in Advanced Melanoma: The Era of Immunotherapy
    Sahni, Sakshi
    Valecha, Gautam
    Sahni, Ankit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2018, 10 (12)
  • [37] Treatment Options for Advanced Melanoma After Anti-PD-1 Therapy
    Nalan Akgul Babacan
    Zeynep Eroglu
    Current Oncology Reports, 2020, 22
  • [38] Prognostic impact of thyroid dysfunctions on progression-free survival in patients with metastatic melanoma treated with anti-PD-1 antibodies
    Frelau, Alexandra
    Jali, Eva
    Campillo-Gimenez, Boris
    Pracht, Marc
    Porneuf, Marc
    Dinulescu, Monica
    Edeline, Julien
    Boussemart, Lise
    Lesimple, Thierry
    MELANOMA RESEARCH, 2021, 31 (03) : 208 - 217
  • [39] Efficacy of combined hypo-fractionated radiotherapy (RT) in anti-PD-1 monotherapy-treated melanoma pts
    Saiag, P.
    Molinier, R.
    Roger, A.
    Boru, B.
    Otmezguine, Y.
    Otz, J.
    Valery, C.
    Fily, A. Blom
    Longvert, C.
    Beauchet, A.
    Funck-Brentano, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S887 - S887
  • [40] Efficacy and safety of anti-PD-1 monotherapy versus anti-PD-1 antibodies plus lenvatinib in patients with advanced hepatocellular carcinoma: a real-world experience
    Liu, Qingyan
    Li, Rong
    Li, Lingling
    Wang, Gaokun
    Ji, Shiyu
    Zheng, Xuan
    Jia, Xiaodong
    Tao, Haitao
    Hu, Yi
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
12345